Introduction To EEPD1: Structure, Function, Interaction and Clinical Application Prospects

Target Name: EEPD1

NCBI ID: G80820

EEPD1

Introduction To EEPD1: Structure, Function, Interaction and Clinical Application Prospects

EEPD1 (endoplasmic reticulum-associated protein 1) is a protein that is expressed in most tissues and cells in the human body. It is a member of the endoplasmic reticulum-associated protein (ERP) family, which includes proteins that play important roles in the endoplasmic reticulum (ER), a system of membrane-enclosed intracellular transport ducts. EEPD1 is responsible for many different biological processes in cells, including protein modification, endocytosis, Golgi transport, and cell cycle regulation. In addition, EEPD1 is closely related to the occurrence and development of many diseases and is therefore considered a potential drug target. This article will introduce the structure, function, interaction and clinical application prospects of EEPD1.

structure

EEPD1 is a 120-amino-acid protein with a molecular weight of 19.8 kDa. It consists of two domains: N-terminal domain and C-terminal domain. The N-terminal domain consists of a transient 伪-helix, a 尾-sheet, and a helical-尾 domain. The C-terminal domain consists of an 伪-helix, a 尾-sheet, and a helix-尾 domain. In addition, EEPD1 also contains an N-terminal hydrogen-rich domain and a C-terminal hydrogen-rich domain, which may be involved in ligand binding and interaction of the protein.

Function

EEPD1 is responsible for many different biological processes within cells. In cells, EEPD1 is mainly involved in protein modification. For example, EEPD1 can react with serine or cysteine 鈥嬧?媟esidues in certain proteins, thereby modifying them. These modifications can affect protein structure, function, and interactions. Within cells, EEPD1 is also involved in the regulation of endocytosis. Endocytosis is an important way for cells to take up macromolecules. EEPD1 can participate in regulating the rate, selectivity and cell membrane permeability of endocytosis. In addition, EEPD1 is also involved in cell cycle regulation. In mitosis, EEPD1 can participate in the assembly and stability of the spindle, thereby participating in chromosome segregation and the progression of cell division.

interaction

EEPD1 interacts with many proteins and these interactions play a key role in its function. EEPD1 can react with serine or cysteine 鈥嬧?媟esidues in a variety of proteins, such as histamine receptors, tyrosine kinases, and G protein-coupled receptors. These interactions can regulate protein structure, function, and interactions, thereby affecting cellular biological processes.

Clinical application prospects

EEPD1 plays an important role in the occurrence and development of many diseases and is therefore considered a potential drug target. Currently, a variety of drugs targeting EEPD1 have entered clinical research. For example, the drug under development, AEB619, is an antihistamine that inhibits histamine receptors, thereby antagonizing the effect of EEPD1 on histamine receptors. In addition, EEPD1 has been used as a target for many drugs, such as anti-tumor drugs, antidepressants, and anti-anxiety drugs. With the deepening of research, EEPD1 will become a much-anticipated drug target and is expected to provide new ideas for the treatment of many diseases.

in conclusion

EEPD1 is a protein that plays multiple biological functions within cells. Its structure, function, and interactions play a crucial role in its biological processes. Currently, EEPD1 has become the target of many drugs and is expected to become a new idea for the treatment of many diseases. Future research will further study the biological functions and drug target properties of EEPD1 to provide new methods for treating diseases.

Protein Name: Endonuclease/exonuclease/phosphatase Family Domain Containing 1

The "EEPD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EEPD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets